ClinicalTrials.Veeva

Menu

Duplex US in Pelvic Congestion Syndrome in Females (PCS)

A

Assiut University

Status

Unknown

Conditions

Pelvic Pain Syndrome

Treatments

Device: Duplex US

Study type

Observational

Funder types

Other

Identifiers

NCT03943381
Duplex US in PCS

Details and patient eligibility

About

To investigate the feasibility of Duplex US in Diagnosis of Pelvic Congestion Syndrome

Full description

  • In the past, a diagnosis of chronic pelvic pain left many women frustrated with few treatment options and a lack of available resources. Their physicians were likewise perplexed, despite the endless acquisition of negative laboratory and imaging data as well as inconclusive consultations obtained. In the last 10 years, improved scientific understanding and increased physician awareness have lessened the confusion surrounding this condition and its distinct association with pelvic congestion syndrome (PCS). Furthermore, refinements of medical and minimally invasive surgical solutions give affected patients more therapeutic choices today.
  • Since anatomical venous variations in the pelvis are common, it is important to know the anatomy of these vessels for treatment planning. Imaging is critical in the evaluation of pelvic varices, both to differentiate them from other condition and also because pelvic varices may be secondary to serious underlying pathology, such as inferior vena caval obstruction, portal hypertension, increased pelvic blood flow, and vascular malformations.

Sonographic findings of pelvic congestion syndrome were dilated left ovarian vein with reversed caudal flow, presence of varicocele, dilated arcuate veins crossing the uterine myometrium, polycystic changes of the ovary, and variable duplex waveform during the Valsalva's maneuver. Combined transabdominal and transvaginal sonography are potentially useful as a noninvasive screening & grading tool for determining which patients with chronic pelvic pain may benefit from selective ovarian venography and transcatheter embolization

Enrollment

25 estimated patients

Sex

Female

Ages

25 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients with signs and symptoms of PCS

Exclusion criteria

  • No

Trial contacts and locations

0

Loading...

Central trial contact

Noha M Attia; Mohamed A Sayed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems